Form 4: Axogen CFO's Stock Holdings Update

Axogen CFO Lindsey Hartley reports vesting of performance-based shares and new restricted stock unit grant.

Summary

• CFO Lindsey Hartley acquired 17,453 shares of Axogen Common Stock due to the vesting of performance-based units on February 26, 2026.
• 6,630 shares were withheld by Axogen on February 26, 2026, to cover tax obligations related to the vested shares, valued at $31.9 per share.
• Hartley was granted 23,000 Restricted Stock Units (RSUs) on February 26, 2026, each representing a contingent right to one share of common stock.
• Following these transactions, Hartley directly owns 55,276 shares of Common Stock and 23,000 Restricted Stock Units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and generally positive update, reflecting the successful vesting of performance-based awards and the ongoing long-term incentive structure for a key executive.

Positives

• The vesting of 17,453 performance-based shares indicates the attainment and certification of certain performance criteria by the company or the individual.
• The grant of 23,000 Restricted Stock Units aligns management's interests with long-term shareholder value and provides a future incentive.

Future Outlook

The Restricted Stock Unit grant establishes a long-term incentive structure for the CFO, with vesting scheduled to occur in stages on February 26, 2028, February 26, 2029, and fully by February 26, 2030.

Industry Context

StockSavvy.ai notes that equity compensation, including performance-based shares and restricted stock units, is a common practice in the biotechnology and medical device industry to incentivize executives and align their interests with long-term company performance. This type of filing is routine for public companies.

Stakeholder Impact

• Shareholders: The vesting of performance-based shares suggests the company met certain goals, which could be viewed positively. The RSU grant aligns executive interests with long-term shareholder value.

Next Steps

• Vesting of 50% of the granted Restricted Stock Units on February 26, 2028.
• Vesting of an additional 25% of the granted Restricted Stock Units on February 26, 2029.
• Full vesting of the remaining 25% of the granted Restricted Stock Units on February 26, 2030.

Key Dates

Recommendation

This Form 4 filing details routine equity compensation events for a key executive, including the vesting of performance-based shares and the grant of new restricted stock units. While the vesting indicates the achievement of certain company or individual performance metrics, and the RSU grant aligns executive incentives with long-term shareholder value, these are standard occurrences and do not present new information that would warrant a change in investment thesis. Therefore, a "hold" recommendation is appropriate as this filing alone does not provide a strong catalyst for either buying or selling.

Keywords

Axogen, AXGN, Form 4, insider trading, stock vesting, restricted stock units, RSU, CFO, Lindsey Hartley, equity compensation